ORIGINAL PAPER
Analysis of bacterial flora of urinary tract infection in hospitalized children with and without congenital urinary tract malformations
 
More details
Hide details
1
Microbiology Laboratory, Centre of Medical Diagnostics, Polish Mother’s Memorial Hospital Research Institute, Łódź, Poland
 
2
Department of Pediatrics, Immunology and Nephrology, Polish Mother’s Memorial Hospital Research Institute, Łódź, Poland
 
3
Department of Pediatrics, Nephrology and Immunology,, Medical University of Łódź, Łódź, Poland
 
 
Submission date: 2022-10-04
 
 
Final revision date: 2023-06-15
 
 
Acceptance date: 2023-06-16
 
 
Publication date: 2023-09-22
 
 
Corresponding author
Marcin Tkaczyk
Prof. Marcin Tkaczyk, Department of Pediatrics, Immunology and Nephrology. Polish Mother’s Memorial Hospital Research Institute, Łódź, Poland
 
 
Pediatr Pol 2023;98(3):208-215
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
The purpose of this study was to determine the relationship between the composition and drug susceptibility of the bacterial flora of urinary tract infections (UTI) and the presence of a congenital urinary tract malformation in children.

Material and methods:
The study included analysis of 515 urine cultures obtained from patients hospitalized at a tertiary referral hospital over a 24-month period. Drug susceptibility of Escherichia coli strains, which are the leading uropathogen in UTI, to antibiotics of the group comprising penicillins, carbapenems, aminoglycosides, fluoroquinolones, and nitrofurantoin and trimethoprim-sulfamethoxazole was determined using the automated Vitek 2 Compact method, the plate-diffusion method and E-tests. The abundance of strains producing an extended-spectrum β-lactamase (ESBL) type resistance mechanism was also analyzed.

Results:
The distribution of cases for Escherichia coli (n = 228) was comparable (p = 0.134) for patients with (40.10%) and without urinary tract defects (46.86%). Comparing the numbers of etiological agents in this group of patients, statistically significant differences were found for infections caused by yeast-like fungi – Candida spp. (p = 0.011) and Pseudomonas aeruginosa (p = 0.002). In terms of Escherichia coli antibiotic resistance, statistically significant differences in their effectiveness were observed for all cephalosporins analyzed, as well as for nitrofurantoin. No such effect was noted for other antibiotics. An extended-spectrum β-lactamase type resistance mechanism was present in Escherichia coli strains isolated from patients with a urinary tract defect – 10.13% of cases, vs. only 2.01% of cases for patients without a malformation (p = 0.016).

Conclusions:
The study showed that the presence of congenital anomalies of the kidney and urinary tract (CAKUT) in children predisposes to Pseudomonas aeruginosa infections, but does not affect the frequency of isolation of Escherichia coli or other strains of bacteria causing urinary tract infections. The presence of CAKUT increases the risk of infection with bacteria with lower sensitivity to the most commonly used first-line antibiotics. Moreover, it increases the risk of Escherichia coli strains with β-lactamase-producing extended substrate spectrum (ESBL+).
REFERENCES (26)
1.
Bochniewska V, Jung A, Zuber J. Urinary tract infections in children. Ped Med Rodz 2012; 8: 12-22.
 
2.
Kot B, Wicha J, Żak-Puławska Z. Susceptibility of Escherichia coli strains isolated from persons with urinary tract infections in 2007–2008 to antimicrobial agents. Prze Epidemiol 2010; 64: 6.
 
3.
Vazouras K, Velali K, Tassiou I, et al. Antibiotic treatment and antimicrobial resistance in children with urinary tract infections. J Glob Antimicrob Resist 2020; 20: 4-10.
 
4.
Baka-Ostrowska M. Urinary tract infection in children. Przegl Urol 2006; 6: 6.
 
5.
Daniel M, Szymanik-Grzelak H, Sierdzinski J, et al. Epidemiology and risk factors of UTIs in children-a single-center observation. J Pers Med 2023; 13: 138.
 
6.
Bell LE, Mattoo TK. Update on childhood urinary tract infection and vesicoureteral reflux. Semin Nephrol 2009; 29: 349-359.
 
7.
Leung AKC, Kao CP, Robson WLM. Urinary tract infection due to Salmonella stanleyville in an otherwise healthy child. J Natl Med Assoc 2005; 97: 281-283.
 
8.
Stein R, Dogan HS, Hoebeke P. European Association of Urology; European Society for Pediatric Urology. Urinary tract infections in children: EAU/ESPU guidelines. Eur Urol 2015; 67: 546-558.
 
9.
Burckhardt I, Panitz J, van der Linden M, Zimmermann S. Streptococcus pneumoniae as an agent of urinary tract infections – a laboratory experience from 2010 to 2014 and further characterization of strains. Diagn Microbiol Infect Dis 2016; 86: 97-101.
 
10.
Kauffman CA, Vazquez JA, Sobel JD, et al. Prospective multicenter surveillance study of funguria in hospitalized patients. The National Institute for Allergy and Infectious Diseases (NIAID) Mycoses Study Group. Clin Infect Dis 2000; 30: 14-18.
 
11.
Brindha SM, Jayashree M, Singhi S, Taneja N. Study of nosocomial urinary tract infections in a pediatric intensive care unit. J Trop Pediatr 2011; 57: 357-362.
 
12.
Isac R, Basaca DG, Olariu IC, et al. Antibiotic resistance patterns of uropathogens causing urinary tract infections in children with congenital anomalies of kidney and urinary tract. Children (Basel) 2021; 8: 585.
 
13.
Miron VD, Filimon C, Cabel T, et al. Urinary tract infections in children: clinical and antimicrobial resistance data from Bucharest area, Romania. Germs 2021; 11: 583-591.
 
14.
Gunduz S, Uludag Altun H. Antibiotic resistance patterns of urinary tract pathogens in Turkish children. Glob Health Res Policy 2018; 3: 10.
 
15.
Pierantoni L, Andreozzi L, Ambretti S, et al. Three-year trend in Escherichia coli antimicrobial resistance among children’s urine cultures in an Italian metropolitan area. Children (Basel) 2021; 8: 597.
 
16.
Lee P, Kim M, Herold BC, Soma VL. Under-utilization of narrow- spectrum antibiotics in the ambulatory management of pediatric UTI: a single-center experience. Front Pediatr 2021; 9: 675759.
 
17.
Alavudeen SS, Asiri AA, Fageeh SA, et al. Evaluation of antibiotic prescribing practices and antimicrobial sensitivity patterns in urinary tract related infectious diseases in pediatric patients. Front Pediatr 2021; 9: 740106.
 
18.
Landau Z, Cherniavsky E, Abofreha S, et al. Epidemiologic, microbiologic and imaging characteristics of urinary tract infections in hospitalized children < 2 years of age diagnosed with anatomic abnormalities of the urinary tract. Pediatr Neonatol 2022; 63: 402-409.
 
19.
Rosado MR, Molina AG, Velasco AL, et al. Urinary tract infection in pediatrics: study of uropathogens and their resistance in a Madrid hospital. Arch Esp Urol 2022; 75: 791-797.
 
20.
Catal F, Bavbek N, Bayrak O, et al. Antimicrobial resistance patterns of urinary tract pathogens and rationale for empirical therapy in Turkish children for the years 2000–2006. Int Urol Nephrol 2009; 41: 953-957.
 
21.
Joya M, Aalemi AK, Baryali AT. Prevalence and antibiotic susceptibility of the common bacterial uropathogen among UTI patients in French Medical Institute for Children. Infect Drug Resist 2022; 15: 4291-4297.
 
22.
Ramos NL, Dzung DT, Stopsack K, et al. Characterisation of uropathogenic Escherichia coli from children with urinary tract infection in different countries. Eur J Clin Microbiol Infect Dis 2011; 30: 1587-1593.
 
23.
Fan NC, Chen HH, Chen CL, et al. Rise of community-onset urinary tract infection caused by extended-spectrum beta-lactamase- producing Escherichia coli in children. J Microbiol Immunol Infect 2014; 47: 399-405.
 
24.
Zerr DM, Miles-Jay A, Kronman MP, et al. Previous antibiotic exposure increases risk of infection with extended-spectrum-beta- lactamase- and ampc-producing Escherichia coli and Klebsiella pneumoniae in pediatric patients. Antimicrob Agents Chemother 2016; 60: 4237-4243.
 
25.
Logan LK, Braykov NP, Weinstein RA, Laxminarayan R. Program CDCEP. Extended-spectrum beta-lactamase-producing and third-generation cephalosporin-resistant enterobacteriaceae in children: trends in the United States, 1999–2011. J Pediatric Infect Dis Soc 2014; 3: 320-328.
 
26.
Topaloglu R, Er I, Dogan BG, et al. Risk factors in community- acquired urinary tract infections caused by ESBL-producing bacteria in children. Pediatr Nephrol 2010; 25: 919-925.
 
Journals System - logo
Scroll to top